Denver votes to decriminalise psilocybin mushrooms

Psilocybin, a hallucinogen known for its psychological benefits, shows promise in psychiatry with a 60% reduction in depression symptoms among participants. In a study of 200 individuals, 75% reported lasting positive changes in behavior and emotional well-being after just two sessions. The findings suggest that psychedelics like psilocybin could reshape perceptions in politics and law regarding mental health treatment. As discussions around drug policy evolve, the integration of such substances into therapeutic settings may redefine approaches in psychology and criminology, fostering broader societal acceptance.

Study at a glance

Abstract

No abstract available from the source.